Vaccine troubles

While a 40-year old man, apparently a business consultant from Chennai, has claimed that he has suffered from adverse reactions to the trial vaccine administered by the Serum Institute of India (SII) during the Phase-III clinical trials, we do not know the full details of the case. This is the vaccine developed by Anglo-Swedish pharmaceutical firm AstraZeneca and University of Oxford where SII is a partner.

Read Full Story>>